- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x 01: 4-[2-cyclopropyl-7-[[(1~{R})-1-naphthalen-2-ylethyl]amino]-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl]piperazine-1-carboxamide
01.1: 8 residues within 4Å:- Chain A: Y.32, F.33, T.325, S.326, V.329
- Chain C: V.321
- Ligands: 01.7, 01.13
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.33
01.7: 7 residues within 4Å:- Chain A: T.325
- Chain B: Y.32, F.33, S.326, V.329
- Ligands: 01.1, 01.13
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:Y.32, B:F.33
01.13: 5 residues within 4Å:- Chain C: Y.32, F.33, S.326
- Ligands: 01.1, 01.7
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:Y.32, C:Y.32, C:F.33
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
NAG.3: 3 residues within 4Å:- Chain A: M.161, E.164, N.165
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.165
NAG.4: 3 residues within 4Å:- Chain A: L.187, N.189, F.207
No protein-ligand interaction detected (PLIP)NAG.5: 3 residues within 4Å:- Chain A: M.283, N.285, S.287
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.287, A:S.287
NAG.9: 3 residues within 4Å:- Chain B: M.161, N.165
- Chain C: L.122
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.165
NAG.10: 5 residues within 4Å:- Chain B: L.187, N.189, F.207, D.249, I.252
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.249
NAG.11: 2 residues within 4Å:- Chain B: N.285, S.287
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.287
NAG.15: 3 residues within 4Å:- Chain C: M.161, E.162, N.165
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:M.161
NAG.16: 3 residues within 4Å:- Chain C: L.187, N.189, F.207
No protein-ligand interaction detected (PLIP)NAG.17: 2 residues within 4Å:- Chain C: N.285, S.287
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.285, C:S.287
- 3 x MG: MAGNESIUM ION
MG.6: 2 residues within 4Å:- Chain A: D.153
- Ligands: ATP.14
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:D.153
MG.12: 2 residues within 4Å:- Chain B: D.153
- Ligands: ATP.2
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:D.153
MG.18: 2 residues within 4Å:- Chain C: D.153
- Ligands: ATP.8
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:D.153
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, G.R. et al., Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy. J.Med.Chem. (2024)
- Release Date
- 2024-09-04
- Peptides
- P2X purinoceptor 3: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x 01: 4-[2-cyclopropyl-7-[[(1~{R})-1-naphthalen-2-ylethyl]amino]-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl]piperazine-1-carboxamide
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x MG: MAGNESIUM ION
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, G.R. et al., Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy. J.Med.Chem. (2024)
- Release Date
- 2024-09-04
- Peptides
- P2X purinoceptor 3: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.